Stockreport

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Merit Medical Systems, Inc.  (MMSI) 
Last merit medical systems, inc. earnings: 4/23 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: merit.com/investors
PDF The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneo [Read more]